IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 23.987
NA - Nord America 9.829
EU - Europa 4.363
SA - Sud America 1.641
AF - Africa 223
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 2
Totale 40.115
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 16.333
US - Stati Uniti d'America 9.406
CN - Cina 3.267
HK - Hong Kong 2.523
IT - Italia 2.024
BR - Brasile 1.202
VN - Vietnam 722
GB - Regno Unito 680
FR - Francia 590
DE - Germania 325
IN - India 274
BD - Bangladesh 219
CA - Canada 211
AR - Argentina 174
MX - Messico 138
NL - Olanda 123
ID - Indonesia 108
ZA - Sudafrica 88
TR - Turchia 85
FI - Finlandia 82
EC - Ecuador 69
JP - Giappone 63
ES - Italia 61
RU - Federazione Russa 59
AU - Australia 57
UA - Ucraina 57
IQ - Iraq 50
PL - Polonia 50
CO - Colombia 49
SA - Arabia Saudita 46
CZ - Repubblica Ceca 39
PY - Paraguay 34
CL - Cile 32
PE - Perù 32
PK - Pakistan 31
SE - Svezia 31
MD - Moldavia 29
UZ - Uzbekistan 28
VE - Venezuela 28
PH - Filippine 27
EE - Estonia 25
CH - Svizzera 22
MA - Marocco 21
LT - Lituania 19
BG - Bulgaria 17
AT - Austria 16
BE - Belgio 16
DZ - Algeria 16
NP - Nepal 16
JM - Giamaica 15
KR - Corea 15
MY - Malesia 15
TH - Thailandia 15
TN - Tunisia 15
EG - Egitto 14
IL - Israele 14
RO - Romania 14
TW - Taiwan 13
UY - Uruguay 13
BH - Bahrain 12
JO - Giordania 12
KE - Kenya 12
CR - Costa Rica 11
KZ - Kazakistan 11
ET - Etiopia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
BA - Bosnia-Erzegovina 9
DO - Repubblica Dominicana 9
HU - Ungheria 9
KW - Kuwait 9
AL - Albania 8
OM - Oman 8
PS - Palestinian Territory 8
IE - Irlanda 7
LB - Libano 7
PT - Portogallo 7
SI - Slovenia 7
BO - Bolivia 6
GT - Guatemala 6
HN - Honduras 6
BY - Bielorussia 5
CY - Cipro 5
GR - Grecia 5
IR - Iran 5
KH - Cambogia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
CI - Costa d'Avorio 4
DM - Dominica 4
GA - Gabon 4
NI - Nicaragua 4
QA - Qatar 4
SN - Senegal 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BB - Barbados 3
DK - Danimarca 3
Totale 40.030
Salva come PNG Salva come JPEG
Città #
San Jose 3.410
Hong Kong 2.508
Singapore 2.142
Ashburn 2.139
Rome 1.506
Hefei 1.203
Boardman 706
Beijing 672
London 556
Lauterbourg 525
Dallas 464
Shanghai 414
Ho Chi Minh City 270
Los Angeles 169
Council Bluffs 161
New York 160
Hanoi 142
San Francisco 138
Santa Clara 138
Munich 134
São Paulo 130
Pune 88
Seattle 88
Mexico City 86
Toronto 83
Amsterdam 69
Washington 62
Rio de Janeiro 52
Turku 50
Johannesburg 47
Tokyo 47
Warsaw 46
Frankfurt am Main 42
Montreal 40
Brooklyn 39
Milan 39
Orem 39
Chennai 37
Brno 34
Da Nang 33
Chicago 32
Melbourne 32
Helsinki 31
Naples 28
Tashkent 28
Atlanta 25
Belo Horizonte 24
Guayaquil 24
Buenos Aires 23
Manchester 23
Stockholm 23
Thái Bình 23
Boston 22
Phoenix 22
Riyadh 22
Baghdad 21
Haiphong 20
Quito 20
Asunción 19
Biên Hòa 19
Buffalo 19
Hangzhou 19
St Louis 19
Brasília 18
Porto Alegre 18
Guangzhou 17
Istanbul 17
New Delhi 17
Ankara 16
Curitiba 16
Denver 16
Ribeirão Preto 16
Secaucus 16
Jeddah 15
Lima 15
Manaus 15
Boydton 14
Charlotte 14
Jakarta 14
West Jordan 14
Burgas 13
Hanover 13
Palermo 13
Poplar 13
Can Tho 12
Canberra 12
Hasselt 12
Madrid 12
Mumbai 12
Osasco 12
Salvador 12
Bangkok 11
Fortaleza 11
Hải Dương 11
Nairobi 11
Ninh Bình 11
Sydney 11
Thái Nguyên 11
Addis Ababa 10
Amman 10
Totale 19.747
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 300
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 272
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 257
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 250
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 250
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 246
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 245
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 240
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 240
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 238
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 237
Early impairment of food intake in patients newly diagnosed with cancer 235
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 234
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 232
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 231
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 231
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 230
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 229
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 223
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 223
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 222
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 221
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 221
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 219
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 218
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 216
Prevention of radiotherapy-induced emesis 216
Premetastatic niche: ready for new therapeutic interventions? 215
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 213
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 213
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 212
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 212
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 212
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 211
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 210
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 204
Docetaxel induced pericardial effusion 203
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 201
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 200
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 198
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 197
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 194
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 191
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 191
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 177
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 167
A giant sarcoma of the parotid gland: A case report and review of the literature 161
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 158
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 157
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 154
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 153
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 139
'Old' and 'new' drugs for the treatment of cancer pain 139
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 138
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 137
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 135
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 134
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 134
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 133
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 132
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 131
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 131
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 129
[Neoplastic hypercalcemia]. 128
Colorectal carcinomas and PTEN/MMAC1 gene mutations 127
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 127
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 127
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 127
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 127
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 125
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 125
Biological effects of cabozantinib on bone microenvironment 125
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 125
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 123
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 123
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 123
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 122
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 121
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]. 121
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 121
An omental mass: any hypothesis? 119
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 119
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 117
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 117
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 115
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 115
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 114
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 114
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 114
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 113
Azygo-tracheal fistula in a complete implantable central venous system 113
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 112
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 111
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 111
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 111
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 110
Idiosyncratic reaction after oxaliplatin infusion 110
Totale 17.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 290.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 290.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022839 0 5 8 11 63 5 6 5 20 22 19 675
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.026 46 228 137 146 186 872 21 131 26 67 78 88
2024/202519.040 311 224 781 138 150 472 324 79 1.660 1.529 6.204 7.168
2025/202618.164 1.669 739 1.263 2.160 674 1.141 4.822 1.601 1.537 1.708 844 6
Totale 40.271